Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101
- Antonius A. Miller
- , Daryl J. Murry
- , Kouros Owzar
- , Donna R. Hollis
- , Lionel D. Lewis
- , Hedy L. Kindler
- , John L. Marshall
- , Miguel A. Villalona-Calero
- , Martin J. Edelman
- , Raymond J. Hohl
- , Stuart M. Lichtman
- , Mark J. Ratain
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations